|
|
|
|
|
|
Novel therapeutic agents for cutaneous T-Cell
lymphoma
Salvia Jain, Jasmine Zain, Owen O'Connor Journal of Hematology & Oncology 2012, 5:24 (17 May 2012)
Abstract | Provisional PDF
|
|
|
|
Pharmacokinetics of Dasatinib for Philadelphia-
Positive Acute Lymphocytic Leukemia with
Acquired T315I mutation
Naoto Takahashi, Masatomo Miura, Stuart A Scott, Takenori Niioka, Kenichi Sawada Journal of Hematology & Oncology 2012, 5:23 (15 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
The significance of low PU.1 expression in patients
with acute promyelocytic leukemia
Xuehua Zhu, Hui Zhang, Maoxiang Qian, Xujie Zhao, Wentao Yang, Ping Wang, Ji Zhang, Kankan Wang Journal of Hematology & Oncology 2012, 5:22 (8 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Recent advances and novel agents for
gastrointestinal stromal tumor (GIST)
Gurpreet Lamb, Samir Ambrale, Byung Lee, Ridhi Gupta, Shamudheen M Rafiyath, Delong Liu Journal of Hematology & Oncology 2012, 5:21 (8 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
Naomi Galili, Pablo Tamayo, Olga B Botvinnik, Jill P Mesirov, Margarita R Brooks, Gail Brown, Azra Raza Journal of Hematology & Oncology 2012, 5:20 (6 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Clinical applications of mesenchymal stem cells
Shihua Wang, Xuebin Qu, Robert Chunhua Zhao Journal of Hematology & Oncology 2012, 5:19 (30 April 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Phase 1 dose-ranging study of ezatiostat
hydrochloride in combination with lenalidomide in
patients with non-deletion (5q) low to intermediate-1
risk myelodysplastic syndrome (MDS)
Azra Raza, Naomi Galili, Deborah Mulford, Scott E. Smith, Gail Brown, David P. Steensma, Roger M. Lyons, Ralph Boccia, Mikkael A. Sekeres, Garcia-Manero Guillermo, Ruben A. Mesa Journal of Hematology & Oncology 2012, 5:18 (30 April 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Deprivation of arginine by recombinant human arginase in prostate cancer cells
Eddy C Hsueh, Stephanie M Knebel, Wai-Hung Lo, Yun-Chung Leung, Paul Ning-Man Cheng, Chung-Tsen Hsueh Journal of Hematology & Oncology 2012, 5:17 (30 April 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells
Chaoquan Hu, Limin Huang, Caroline Gest, Xiaodong Xi, Anne Janin, Claudine Soria, Hong Li, He Lu Journal of Hematology & Oncology 2012, 5:16 (25 April 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
David Z Chang, Ying Ma, Baoan Ji, Yan Liu, Patrick Hwu, James L Abbruzzese, Craig Logsdon, Huamin Wang Journal of Hematology & Oncology 2012, 5:15 (4 April 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment
Kyung Taek Hong, Hyoung Jin Kang, Nam Hee Kim, Min Sun Kim, Ji Won Lee, Hyery Kim, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn Journal of Hematology & Oncology 2012, 5:14 (30 March 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
Catherine Labbaye, Ugo Testa Journal of Hematology & Oncology 2012, 5:13 (27 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Véronique Gelsi-Boyer, Mandy Brecqueville, Raynier Devillier, Anne Murati, Marie-Joelle Mozziconacci, Daniel Birnbaum Journal of Hematology & Oncology 2012, 5:12 (21 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Comparative mitochondrial proteomics: perspective in human diseases
Yujie Jiang, Xin Wang Journal of Hematology & Oncology 2012, 5:11 (18 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
Meng Lv, Xiao-Jun Huang Journal of Hematology & Oncology 2012, 5:10 (18 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Recent updates on the role of microRNAs in prostate cancer
Oudai Hassan, Aamir Ahmad, Seema Sethi, Fazlul H Sarkar Journal of Hematology & Oncology 2012, 5:9 (14 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
Jie Li, Oluwole Fadare, Li Xiang, Beihua Kong, Wenxin Zheng Journal of Hematology & Oncology 2012, 5:8 (9 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
MicroRNAs in B cell development and malignancy
Thilini R Fernando, Norma I Rodriguez-Malave, Dinesh S Rao Journal of Hematology & Oncology 2012, 5:7 (8 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Altered expression of the TCR signaling related genes CD3 and FcepsilonRIgamma in patients with aplastic anemia
Bo Li, Sichu Liu, Yuzhe Niu, Su Fang, Xiuli Wu, Zhi Yu, Shaohua Chen, Lijian Yang, Yangqiu Li Journal of Hematology & Oncology 2012, 5:6 (8 March 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
|
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
Sadudee Chotirat, Wanna Thongnoppakhun, Orathai Promsuwicha, Chetsada Boonthimat, Chirayu U Auewarakul Journal of Hematology & Oncology 2012, 5:5 (7 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
Yuka Sugimoto, Mikkael A Sekeres, Hideki Makishima, Fabiola Traina, Valeria Visconte, Anna Jankowska, Andres Jerez, Hadrian Szpurka, Christine L O'Keefe, Kathryn Guinta, Manuel Afable, Ramon Tiu, Kathy L McGraw, Alan F List, Jaroslaw Maciejewski Journal of Hematology & Oncology 2012, 5:4 (5 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Current management and novel agents for malignant melanoma
Byung Lee, Nikhil Mukhi, Delong Liu Journal of Hematology & Oncology 2012, 5:3 (14 February 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
|
Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis
Raquel Tognon, Elainy PL Gasparotto, Renata P Neves, Natália S Nunes, Aline F Ferreira, Patrícia VB Palma, Simone Kashima, Dimas T Covas, Mary Santana, Elizabeth X Souto, Maria Aparecida Zanichelli, Belinda P Simões, Ana Maria de Souza, Fabíola A Castro Journal of Hematology & Oncology 2012, 5:2 (2 February 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
Noriyoshi Iriyama, Yuta Yoshino, Bo Yuan, Akira Horikoshi, Yukio Hirabayashi, Yoshihiro Hatta, Hiroo Toyoda, Jin Takeuchi Journal of Hematology & Oncology 2012, 5:1 (24 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
|
Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model
Dan Xu, Teresa M O, Archil Shartava, Taylor C Fowles, Jianchang Yang, Louis M Fink, David C Ward, Martin C Mihm, Milton Waner, Yupo Ma Journal of Hematology & Oncology 2011, 4:54 (22 December 2011)
Abstract | Full text | PDF | PubMed
|
